The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment (tx) intensity for patient groups by predefined tx aims and clinical characteristics in the management of patients (pts) with metastatic colorectal cancer (MCRC): Findings from a population-based survey in Germany
D. Arnold
No relevant relationships to disclose
L. Kellermann
No relevant relationships to disclose
H. Kröning
No relevant relationships to disclose
C. Goerg
No relevant relationships to disclose
D. Buschmann
No relevant relationships to disclose
H. Schmoll
No relevant relationships to disclose